LUNG HYPERINFLATION

This adverse event was reported 860 times

LUNG HYPERINFLATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Interleukin-5 Antagonist [EPC] 101 0.1468
1 Provitamin D2 Compound [EPC] 38 0.0013
2 Blood Viscosity Reducer [EPC] 5 0.0012
3 Anti-IgE [EPC] 84 0.0010
4 beta Lactamase Inhibitor [EPC] 4 0.0009
5 Plasma Volume Expander [EPC] 2 0.0006
6 Calcitonin [EPC] 2 0.0006
7 Methylxanthine [EPC] 34 0.0006
8 alpha-Hydroxy Acid [EPC] 1 0.0005
9 General Anesthetic [EPC] 19 0.0004
See all drug classes enriched for association with LUNG HYPERINFLATION